ME smokers develop lung disease at younger age
Wednesday, April 02 - 2008 at 07:39
A new study has found that people from Middle Eastern countries are developing lung disease at a younger age, reported Gulf News. The 46-country Greatest International Antibiotic Trial (Giant) studied the prevalence of acute exacerbate chronic bronchitis, a form of lung disease, and the effectiveness of Bayer Schering Pharma's antibiotic in treating it. It found a majority of the 4,300 subjects in the Middle East were reporting the disease at 48.5 years old, the youngest compared to other regions. The average age for lung disease in Latin America was 63.1 years, followed by Europe at 60.5 and Asia-Pacific with 57.1 years.
Readers' recommendation
This story is currently rated 6.86 of 10 based on 14 readers' recommendations
This story is currently rated 6.86 of 10 based on 14 readers' recommendations
Also consider reading:
- » New rules for pharmacies
- » No clinics for dentists in Saudi
- » Boston dental center opens in DHCC
- » Dubai to switch off lights
- » Pfizer makes Dubai its regional HQ
- » Sharjah issues smoking ban
- » Sterilisation for UAE women now legal at private hospitals
- » Mozarella cancer scare in Qatar
- » Paediatrics get CME credit hours
- » Qatar only wants healthy beef
Jeff Florian, Senior ReporterWednesday, April 02 - 2008 at 07:39 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Index : Healthcare
Browse related articles
Browse related articlesToday's most read articles:
Most read articles the past week:
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.



Web Feeds